Sophia Genetics SA (SOPH) — Financial Flexibility Index
Sophia Genetics SA (SOPH) has a Financial Flexibility Index of -0.08x as of September 2025. Free cash flow of $-8.69 Million (operating CF $-8.79 Million minus capex $106.00K) represents 0% of total liabilities ($102.77 Million). Check SOPH goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sophia Genetics SA Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Sophia Genetics SA across 6 annual periods. For the full cash flow conversion analysis, see Sophia Genetics SA (SOPH) cash flow conversion.
Annual Financial Flexibility Index for Sophia Genetics SA (2019–2024)
Year-by-year free cash flow to debt coverage for Sophia Genetics SA. Explore Sophia Genetics SA cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.59x | $-34.65 Million | $-42.82 Million | $58.82 Million | ▲ +18.1% |
| 2023 | -0.72x | $-39.35 Million | $-48.58 Million | $54.71 Million | ▲ +47.4% |
| 2022 | -1.37x | $-59.71 Million | $-70.09 Million | $43.71 Million | ▼ -19.3% |
| 2021 | -1.15x | $-51.27 Million | $-57.94 Million | $44.77 Million | ▼ -26.9% |
| 2020 | -0.90x | $-28.53 Million | $-31.73 Million | $31.61 Million | ▲ +7.4% |
| 2019 | -0.97x | $-28.65 Million | $-31.68 Million | $29.40 Million | — |